What we have achieved
We have been active in research and development, and advocacy. Together with a group of concerned investigators, we helped create the Chagas Clinical Research Platform, a network of over 400 people from 25 countries, to utilize and strengthen capacity in endemic countries.
First-ever treatment for children. With our partners, we developed and registered the first-ever formulations of benznidazole for treating infants and children with Chagas disease.
What we are doing for people living with Chagas disease
Our goal is to make treatment safer and more effective. We are also working to improve access to testing and treatment.
Building capacity, uniting expertise
Research platforms and consortiums that bring together researchers and strengthen research capacities in low- and middle-income countries are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.
Making medical history for neglected patients
We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.
Get in touch
Support us
Work with us
-
Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License